>
This is the future we shall bring into being
Elon Musk's Vision For The Future Looks Like A Movie
Phosphorus Munitions Fired by Israel Burn Groves, Orchards in Southern Lebanon
Iran's IRGC Warns It Will Expand 'Geography of the War' If the US Attacks Again
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal
Quantum compass takes flight on Northrop's Lumberjack drone
Terrifying AI Behavior Even Its Creators Couldn't Explain
WW3 Near-Miss? AI Hallucinated Nuclear Weapons Components Aboard Chinese Vessel Bound For Iran
Stripe Is Building the Toll Road for the Machine Economy
Toyota Dakar hopeful swaps twin-turbo V6 for hydrogen fuel cells
4-min turbo-inflatable cubic camp castle is now available in the USA
Researchers Used Claude To Hack OpenAI Employee Accounts
Chinese Scientists Develop New Oil Refining Method That Cuts Energy Use by 90%
Scientists from the Salk Institute say the safe and effective technique works by partially resetting cells that impact skin, eyesight, muscles, and the brain. The breakthrough may be able to extend life and help people gain the ability to become more resistant to stress, injury, and disease.
While it may appear to be the Holy Grail of anti-aging research, promising eternal youth, the team cautions that they've only successfully tested the treatment on mice so far. Animals at the late stage of their lives treated with cellular rejuvenation therapy started to show signs of getting younger after just seven months.
New tests are now underway to determine whether the treatment only "pauses" or actually reverses aging. In the study, the researchers note that all cells carry a molecular clock that records the passage of time. By adding a mixture of four reprogramming molecules, known as the Yamanaka factors, the cells reset the clock to their original patterns.
Turning back the clock in less than a year?
The scientists tested three groups of mice at varying ages equivalent to humans being 35, 50, and 80 years-old (12 months, 15 months, and 25 months in mice). There were no blood cell alterations or neurological changes in the mice that received the treatment. The team also found no cancers in any of the groups.